$2.3m Government Grant approved
Good afternoon,
I am pleased to report that an anti-money laundering fintech project Novatti (ASX: NOV) will lead has been approved for a $2.3 million grant under the Australian Government’s Cooperative Research Centres Projects Grants program.
The project will focus on developing a digital platform consisting of innovative anti-fraud and anti-money laundering techniques, to align crypto transactions with traditional payment options such as credit cards. It will allow consumers, merchants, and exchanges to acquire, verify and transfer crypto with trust and scalability while conducting daily business. Thus, it will modernise Australian industries to take the lead in leveraging such currencies globally.
Concerns over cybersecurity have greatly increased over recent years where it has become the most critical corporate risk.
There is a growing need to develop innovative new solutions that can prevent fraud and money laundering in the digital space. With Novatti’s fintech and regtech suite, we are well positioned to address these risks.
Through this collaborative project and with the support of Government funding, we are seeking to provide an innovative solution that can mitigate these risks and hence enabling digital asset transactions to support long-term growth in Novatti’s financial transactions and payments revenues.
The first $830k is due for reimbursement by 30 June 2023 with the project and funding to run through to November 2025. I look forward to bringing you news on this project as it progresses.
Kind regards,
Peter Cook
Managing Director
Novatti Group Limited
Investors can view all Novatti announcements and discuss our latest news at the Novatti Investor Community.
Shareholders can also update their mailing preferences online via our share registry Automic.-->
-->
International Bank of Australia Presentation
Released 7 November 2022
-->
Novatti Digital Payment Services Explainer
- Forums
- ASX - By Stock
- NOV
- Ann: $2.3m Government Grant approved
Ann: $2.3m Government Grant approved, page-5
Featured News
Add NOV (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.3¢ |
Change
0.001(3.13%) |
Mkt cap ! $13.40M |
Open | High | Low | Value | Volume |
3.3¢ | 3.3¢ | 3.3¢ | $2.128K | 64.49K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 231375 | 3.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.3¢ | 97724 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 219375 | 0.032 |
7 | 336731 | 0.031 |
12 | 660700 | 0.030 |
2 | 517275 | 0.029 |
3 | 271156 | 0.028 |
Price($) | Vol. | No. |
---|---|---|
0.033 | 97724 | 2 |
0.034 | 210000 | 1 |
0.036 | 170030 | 2 |
0.037 | 275029 | 2 |
0.039 | 465917 | 3 |
Last trade - 15.48pm 13/11/2024 (20 minute delay) ? |
Featured News
NOV (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online